Supplementary Figure from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/Her2-Negative Advanced Breast Cancer After Progression on Aromatase Inhibitor
                        AuthID
P-013-6E5
                
    P-013-6E5
 
    
                     
                    